Rezultati - Jinghui Dong
- Showing 1 - 18 results of 18
-
1
-
2
-
3
-
4
-
5
-
6
Calcitriol protects renovascular function in hypertension by down-regulating angiotensin II type 1 receptors and reducing oxidative stress od Jinghui Dong, Siu Ling Wong, Chi Wai Lau, Hung Kay Lee, Chi‐Fai Ng, Lihong Zhang, Xiaoqiang Yao, Zhen‐Yu Chen, Paul M. Vanhoutte, Yü Huang
Izdano 2012Artigo -
7
Deep learning-based automatic segmentation for size and volumetric measurement of breast cancer on magnetic resonance imaging od Wenyi Yue, Hongtao Zhang, Juan Zhou, Guang Li, Zhe Tang, Zeyu Sun, Jianming Cai, Ning Tian, Shen Gao, Jinghui Dong, Yuan Liu, Xu Bai, Fugeng Sheng
Izdano 2022Artigo -
8
Persistent Viral Presence Determines the Clinical Course of the Disease in COVID-19 od De Chang, Peng Zhao, Dawei Zhang, Jinghui Dong, Zhe Xu, Guang Yang, Boyu Li, Hongxia Liu, Boan Li, Cheng‐Feng Qin, Xiaohua Peng, Fu‐Sheng Wang, Lixin Xie, Chen Zhu, Charles S. Dela Cruz, Lokesh Sharma, Enqiang Qin
Izdano 2020Artigo -
9
Pathological findings of COVID-19 associated with acute respiratory distress syndrome od Zhe Xu, Lei Shi, Yijin Wang, Jiyuan Zhang, Lei Huang, Chao Zhang, Shuhong Liu, Peng Zhao, Hongxia Liu, Li Zhu, Yanhong Tai, Changqing Bai, Tingting Gao, Jin‐Wen Song, Peng Xia, Jinghui Dong, Jingmin Zhao, Fu‐Sheng Wang
Izdano 2020Artigo -
10
Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial od Sattva S. Neelapu, Michael Dickinson, Javier Muñoz, Matthew L. Ulrickson, Catherine Thiéblemont, Olalekan O. Oluwole, Alex F. Herrera, Chaitra S. Ujjani, Yi Lin, Peter A. Riedell, Natasha Kekre, Sven de Vos, Christine Lui, Francesca Milletti, Jinghui Dong, Hairong Xu, Julio C. Chávez
Izdano 2022Artigo -
11
Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial od Lei Shi, Xin Yuan, Weiqi Yao, Siyu Wang, Chao Zhang, Bo Zhang, Jin‐Wen Song, Lei Huang, Zhe Xu, Junliang Fu, Yuanyuan Li, Ruonan Xu, Tiantian Li, Jinghui Dong, Jianming Cai, Genshi Li, Yunbo Xie, Ming Shi, Yonggang Li, Yu Zhang, Wei‐Fen Xie, Fu‐Sheng Wang
Izdano 2021Artigo -
12
Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma od Max S. Topp, Tom van Meerten, Roch Houot, Monique C. Minnema, Krimo Bouabdallah, Pieternella J. Lugtenburg, Catherine Thiéblemont, Martin Wermke, Kevin Song, Irit Avivi, John Kuruvilla, Ulrich Dührsen, Yan Zheng, Saran Vardhanabhuti, Jinghui Dong, Adrian Bot, John M. Rossi, Vicki Plaks, Marika Sherman, Jenny J. Kim, A. Kerber, Marie José Kersten
Izdano 2021Artigo -
13
Human mesenchymal stem cell therapy in severe COVID-19 patients: 2-year follow-up results of a randomized, double-blind, placebo-controlled trial od Tiantian Li, Bo Zhang, Hui Fang, Ming Shi, Weiqi Yao, Yuanyuan Li, Chao Zhang, Jin‐Wen Song, Lei Huang, Zhe Xu, Xin Yuan, Junliang Fu, Cheng Zhen, Yu Zhang, Ze-Rui Wang, Ziying Zhang, Mengqi Yuan, Tengyun Dong, Ruidan Bai, Lulu Zhao, Jianming Cai, Jinghui Dong, Jianzeng Zhang, Wei‐Fen Xie, Yonggang Li, Lei Shi, Fu‐Sheng Wang
Izdano 2023Artigo -
14
Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 patients: 3-year follow-up of a randomized, double-blind, placebo-controlled trial od Mengqi Yuan, Le Song, Ze-Rui Wang, Ziying Zhang, Ming Shi, Junli He, Qiong Mo, Ning Zheng, Weiqi Yao, Yu Zhang, Tengyun Dong, Yuanyuan Li, Chao Zhang, Jin‐Wen Song, Lei Huang, Zhe Xu, Xin Yuan, Junliang Fu, Cheng Zhen, Jianming Cai, Jinghui Dong, Jianzeng Zhang, Wei‐Fen Xie, Yonggang Li, Bo Zhang, Lei Shi, Fu‐Sheng Wang
Izdano 2025Artigo -
15
Long-Term (≥4 Year and ≥5 Year) Overall Survival (OS) By 12- and 24-Month Event-Free Survival (EFS): An Updated Analysis of ZUMA-1, the Pivotal Study of Axicabtagene Ciloleucel (Ax... od Caron A. Jacobson, Frederick L. Locke, Armin Ghobadi, David B. Miklos, Lazaros J. Lekakis, Olalekan O. Oluwole, Yi Lin, Brian T. Hill, John M. Timmerman, Abhinav Deol, Patrick M. Reagan, Patrick J. Stiff, Ian W. Flinn, Umar Farooq, André Goy, Javier Muñoz, Tanya Siddiqi, Rhine R. Shen, Adrian Bot, Jinghui Dong, Kanwarjit Singh, Clare Spooner, Roshan Karalliyadda, Jenny J. Kim, Yan Zheng, Sattva S. Neelapu
Izdano 2021Artigo -
16
Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external hist... od Bijal Shah, Armin Ghobadi, Olalekan O. Oluwole, Aaron C. Logan, Nicolas Boissel, Ryan D. Cassaday, Thibaut Leguay, Michael R. Bishop, Max S. Topp, Dimitrios Tzachanis, Kristen M. O’Dwyer, Martha Arellano, Yi Lin, Maria R. Baer, Gary J. Schiller, Jae H. Park, Marion Subklewe, Mehrdad Abedi, Monique C. Minnema, William G. Wierda, Daniel J. DeAngelo, Patrick J. Stiff, Deepa Jeyakumar, Jinghui Dong, Sabina Adhikary, Lang Zhou, Petra Schuberth, Imi Faghmous, Behzad Kharabi Masouleh, Roch Houot
Izdano 2022Artigo -
17
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study od Bijal Shah, Armin Ghobadi, Olalekan O. Oluwole, Aaron C. Logan, Nicolas Boissel, Ryan D. Cassaday, Thibaut Leguay, Michael R. Bishop, Max S. Topp, Dimitrios Tzachanis, Kristen M. O’Dwyer, Martha Arellano, Yi Lin, Maria R. Baer, Gary J. Schiller, Jae H. Park, Marion Subklewe, Mehrdad Abedi, Monique C. Minnema, William G. Wierda, Daniel J. DeAngelo, Patrick J. Stiff, Deepa Jeyakumar, Chaoling Feng, Jinghui Dong, Tong Shen, Francesca Milletti, John M. Rossi, Remus Vezan, Behzad Kharabi Masouleh, Roch Houot
Izdano 2021Artigo -
18
5-Year Follow-Up Supports Curative Potential of Axicabtagene Ciloleucel in Refractory Large B-Cell Lymphoma (ZUMA-1) od Sattva S. Neelapu, Caron A. Jacobson, Armin Ghobadi, David B. Miklos, Lazaros J. Lekakis, Olalekan O. Oluwole, Yi Lin, Ira Braunschweig, Brian T. Hill, John M. Timmerman, Abhinav Deol, Patrick M. Reagan, Patrick J. Stiff, Ian W. Flinn, Umar Farooq, André Goy, Peter A. McSweeney, Javier Muñoz, Tanya Siddiqi, Julio C. Chávez, Alex F. Herrera, Nancy L. Bartlett, Adrian A. Bot, Rhine R. Shen, Jinghui Dong, Kanwarjit Singh, Harry Miao, Jenny J. Kim, Yan Zheng, Frederick L. Locke
Izdano 2023Artigo
Iskalna orodja:
Sorodne teme
Internal medicine
Medicine
Gastroenterology
Surgery
Biology
Pathology
Adverse effect
Coronavirus disease 2019 (COVID-19)
Disease
Infectious disease (medical specialty)
Oncology
Alternative medicine
Biochemistry
Cancer
Endocrinology
Lymphoma
Oxidative stress
Physics
Placebo
Receptor
Astrobiology
Astrocyte
Bone marrow
Central nervous system
Chemistry
Chemotherapy
Chimeric antigen receptor
Clinical endpoint
Clinical trial
Cytokine release syndrome